Updates on the phase II and re-treatment study of AZD6244 (selumetinib) for children with recurrent or refractory pediatric low grade glioma: A Pediatric Brain Tumor Consortium (PBTC) Study Meeting Abstract
| Authors: | Fangusaro, J. R.; Onar-Thomas, A.; Poussaint, T. Y.; Wu, S. J.; Ligon, A. H.; Lindeman, N. I.; Banerjee, A.; Packer, R.; Kilburn, L. B.; Pollack, I. F.; Qaddoumi, I. A.; Fisher, P. G.; Dhall, G.; Baxter, P. A.; Kreissman, S. G.; Doyle, L. A.; Smith, M. A.; Fouladi, M.; Dunkel, I. J. |
| Abstract Title: | Updates on the phase II and re-treatment study of AZD6244 (selumetinib) for children with recurrent or refractory pediatric low grade glioma: A Pediatric Brain Tumor Consortium (PBTC) Study |
| Meeting Title: | 18th International Symposium on Pediatric Neuro-Oncology (ISPNO 2018) |
| Journal Title: | Neuro-Oncology |
| Volume: | 20 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2018 Jun 30-Jul 8 |
| Meeting Location: | Denver, CO |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-06-01 |
| Start Page: | i214 |
| Language: | English |
| DOI: | 10.1093/neuonc/noy109 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: LTBK-01 -- Erratum issued, see DOI: 10.1093/neuonc/noac029 |
